 Canada Pension Plan Investment Board boosted its position in Nektar Therapeutics NASDAQ:NKTR by 1,184.8 in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 31,709 shares of the biopharmaceutical companys stock after purchasing an additional 29,241 shares during the quarter. Canada Pension Plan Investment Boards ... 